Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Jenner

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|June 18, 2010
The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II studyStephen A Schey, Gareth J Morgan, Karthik Ramasamy, et al.
Nature Communications|May 17, 2023
Elucidating the molecular programming of a nonlinear non-ribosomal peptide synthetase responsible for fungal siderophore biosynthesisMatthew Jenner, Yang Hai, Hong H Nguyen, et al.
Nature Chemical Biology|January 9, 2018
Mechanism of intersubunit ketosynthase-dehydratase interaction in polyketide synthasesMatthew Jenner, Simone Kosol, Daniel Griffiths, et al.
European Journal of Haematology|April 9, 2020
DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre studyFaouzi Djebbari, Kanchana De Abrew, Beena Salhan, et al.
Nature Communications|January 11, 2022
Aminoacyl chain translocation catalysed by a type II thioesterase domain in an unusual non-ribosomal peptide synthetaseShan Wang, William D G Brittain, Qian Zhang, et al.
Nature Communications|July 1, 2026
Molecular basis for depsipeptide HDAC inhibitor combinatorial biosynthesisMunro Passmore, Xinyun Jian, Xinyi Zhao, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Molecular basis for short-chain thioester hydrolysis by acyl hydrolase domains in <i>trans</i> -acyltransferase polyketide synthasesChristopher D Fage, Munro Passmore, Ben P Tatman, et al.
Ejhaem|June 18, 2025
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR studyDipal Mehta, Robert Cicero, Laura Chiecchio, et al.
Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.
Haematologica|December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trialCharlotte Pawlyn, David Cairns, Tom Menzies, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|June 18, 2010
The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II studyStephen A Schey, Gareth J Morgan, Karthik Ramasamy, et al.
Nature Communications|May 17, 2023
Elucidating the molecular programming of a nonlinear non-ribosomal peptide synthetase responsible for fungal siderophore biosynthesisMatthew Jenner, Yang Hai, Hong H Nguyen, et al.
Nature Chemical Biology|January 9, 2018
Mechanism of intersubunit ketosynthase-dehydratase interaction in polyketide synthasesMatthew Jenner, Simone Kosol, Daniel Griffiths, et al.
European Journal of Haematology|April 9, 2020
DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre studyFaouzi Djebbari, Kanchana De Abrew, Beena Salhan, et al.
Nature Communications|January 11, 2022
Aminoacyl chain translocation catalysed by a type II thioesterase domain in an unusual non-ribosomal peptide synthetaseShan Wang, William D G Brittain, Qian Zhang, et al.
Nature Communications|July 1, 2026
Molecular basis for depsipeptide HDAC inhibitor combinatorial biosynthesisMunro Passmore, Xinyun Jian, Xinyi Zhao, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Molecular basis for short-chain thioester hydrolysis by acyl hydrolase domains in <i>trans</i> -acyltransferase polyketide synthasesChristopher D Fage, Munro Passmore, Ben P Tatman, et al.
Ejhaem|June 18, 2025
Risk adapted therapy for newly diagnosed multiple myeloma delivered through local cytogenetic laboratories in a National Clinical Trial: UKMRA RADAR studyDipal Mehta, Robert Cicero, Laura Chiecchio, et al.
Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.
Haematologica|December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trialCharlotte Pawlyn, David Cairns, Tom Menzies, et al.
Pageof 8